← Back to Clinical Trials
Recruiting NCT05395767

NCT05395767 LIVing Donor Allograft for Anterior Cruciate Ligament Reconstruction Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05395767
Status Recruiting
Phase
Sponsor Maidstone & Tunbridge Wells NHS Trust
Condition ACL
Study Type INTERVENTIONAL
Enrollment 40 participants
Start Date 2021-09-15
Primary Completion 2026-09

Trial Parameters

Condition ACL
Sponsor Maidstone & Tunbridge Wells NHS Trust
Study Type INTERVENTIONAL
Phase N/A
Enrollment 40
Sex ALL
Min Age 8 Years
Max Age 17 Years
Start Date 2021-09-15
Completion 2026-09
Interventions
Endoscopic Anterior Cruciate Ligament reconstruction using living donor hamstring allograft from a parent donor

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The Anterior Cruciate Ligament (ACL) is a major stabiliser of the knee. ACL rupture is being increasingly identified in children and skeletally immature patients. The current advice in younger patients is usually to undergo ACL reconstruction. The choice of an ideal graft in children is difficult This study will use a technique involves the use of hamstring tendons from a living donor, where the adult (usually a parent) agrees to donate their hamstring tendons, which are dissected out of them and implanted into the child

Eligibility Criteria

Inclusion Criteria: * Patients aged 8 to 17 years inclusive and have a clinically and radiologically confirmed ACL rupture that requires reconstruction. * Patients who have had previous surgery for meniscal pathology . * Patients with current meniscal pathology * The child and their responsible adult are in agreement with the choice to undergo anterior cruciate ligament reconstruction using living donor allograft. * Donors has not previously undergone tendon harvest on the chosen donor limb * Patients are willing to attend follow up appointments and agree to fill in knee questionnaires and allow instrumented knee ligament testing. Exclusion Criteria: * Patients who have previously undergone ACL surgery on the same limb (and therefore require revision surgery) * Patients who are immunosuppressed, or receiving immunosuppressive therapy * Patients who are unable to attend follow-up appointments for continued research purposes. * Donors who have previously undergone hamstring tendon surger

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology